RT Journal Article
T1 Home parenteral nutrition provision modalities for chronic intestinal failure in adult patients: An international survey.
A1 Pironi, Loris
A1 Steiger, Ezra
A1 Brandt, Chrisoffer
A1 Joly, Francisca
A1 Wanten, Geert
A1 Chambrier, Cecile
A1 Aimasso, Umberto
A1 Sasdelli, Anna Simona
A1 Zeraschi, Sarah
A1 Kelly, Darlene
A1 Szczepanek, Kinga
A1 Jukes, Amelia
A1 Di-Caro, Simona
A1 Theilla, Miriam
A1 Kunecki, Marek
A1 Daniels, Joanne
A1 Serlie, Mireille
A1 Poullenot, Florian
A1 Wu, Jian
A1 Cooper, Sheldon C
A1 Rasmussen, Henrik H
A1 Compher, Charlene
A1 Seguy, David
A1 Crivelli, Adriana
A1 Pagano, Maria C
A1 Hughes, Sarah-Jane
A1 Guglielmi, Francesco W
A1 Kozjek, Nada Rotovnik
A1 Schneider, Stéphane M
A1 Gillanders, Lyn
A1 Ellegard, Lars
A1 Thibault, Ronan
A1 Matras, Przemysław
A1 Zmarzly, Anna
A1 Matysiak, Konrad
A1 Van Gossum, Andre
A1 Forbes, Alastair
A1 Wyer, Nicola
A1 Taus, Marina
A1 Virgili, Nuria M
A1 O'Callaghan, Margie
A1 Chapman, Brooke
A1 Osland, Emma
A1 Cuerda, Cristina
A1 Sahin, Peter
A1 Jones, Lynn
A1 Won-Lee, Andre Dong
A1 Masconale, Luisa
A1 Orlandoni, Paolo
A1 Izbeki, Ferenc
A1 Spaggiari, Corrado
A1 Bueno, Marta
A1 Doitchinova-Simeonova, Maryana
A1 Garde, Carmen
A1 Serralde-Zuñiga, Aurora E
A1 Olveira, Gabriel
A1 Krznaric, Zeljko
A1 Czako, Laszlo
A1 Kekstas, Gintautas
A1 Sanz-Paris, Alejandro
A1 Jauregui, Estrella Petrina
A1 Murillo, Ana Zugasti
A1 Schafer, Eszter
A1 Arends, Jann
A1 Suarez-Llanos, Jose P
A1 Lal, Simon
K1 Cancer
K1 Home parenteral nutrition
K1 Intestinal failure
K1 Intravenous supplementation
AB The safety and effectiveness of a home parenteral nutrition (HPN) program depends both on the expertise and the management approach of the HPN center. We aimed to evaluate both the approaches of different international HPN-centers in their provision of HPN and the types of intravenous supplementation (IVS)-admixtures prescribed to patients with chronic intestinal failure (CIF). In March 2015, 65 centers from 22 countries enrolled 3239 patients (benign disease 90.1%, malignant disease 9.9%), recording the patient, CIF and HPN characteristics in a structured database. The HPN-provider was categorized as health care system local pharmacy (LP) or independent home care company (HCC). The IVS-admixture was categorized as fluids and electrolytes alone (FE) or parenteral nutrition, either commercially premixed (PA) or customized to the individual patient (CA), alone or plus extra FE (PAFE or CAFE). Doctors of HPN centers were responsible for the IVS prescriptions. HCC (66%) was the most common HPN provider, with no difference noted between benign-CIF and malignant-CIF. LP was the main modality in 11 countries; HCC prevailed in 4 European countries: Israel, USA, South America and Oceania (p  This is the first study to demonstrate that HPN provision and the IVS-admixture differ greatly among countries, among HPN centers and between benign-CIF and cancer-CIF. As both HPN provider and IVS-admixture types may play a role in the safety and effectiveness of HPN therapy, criteria to homogenize HPN programs are needed so that patients can have equal access to optimal CIF care.
PB Elsevier
YR 2019
FD 2019-03-25
LK http://hdl.handle.net/10668/13844
UL http://hdl.handle.net/10668/13844
LA en
NO Pironi L, Steiger E, Brandt C, Joly F, Wanten G, Chambrier C, et al. Home parenteral nutrition provision modalities for chronic intestinal failure in adult patients: An international survey. Clin Nutr. 2020 Feb;39(2):585-591
DS RISalud
RD Apr 8, 2025